BIOHEM a. s.
ActiveKey figures
Key figures
2025Dividends
calculatedDistributed as dividends 2 459 290 € (49 % of distributable profit).
Summary: BIOHEM a. s.
What kind of company is it?
BIOHEM a. s. (IČO 54519098) is a joint-stock company (a.s.). The company was incorporated in 2022 and has existed for 4 years. Registered office according to the register: Trenčín. Main activity according to the Statistical Office: veľkoobchod s farmaceutickým a zdravotníckym tovarom (SK NACE 4646). Size category by number of employees: 25–49 employees.
Who runs the company and who owns it?
The statutory body has 3 members. According to the register, the company has one shareholder. The supervisory board has 3 members. The registered capital is 25 000 €.
How is the company doing financially?
Revenue for 2025 was 30 128 810 €, up 13,8 % on the previous year (26 481 821 €). From 2022 to 2025, revenue grew by an average of 30,3 % per year. This is the highest revenue in the reported years (2022–2025). Net profit for 2025 was 2 078 318 € (6,9 % of revenue). The company was profitable in all 4 reported years. Personnel costs for 2025 were 2 930 943 €. At the end of 2025 the company had total assets of 43 683 854 € and equity of 4 703 643 € (equity ratio 10,8 %).
Where does the data come from and how current is it?
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 11. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.
Summary of annual reports2022–2025
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Revenue (net turnover) | 13 626 988 | 22 985 103 | 26 481 821 | 30 128 810 |
| Profit for the reporting year | 266 354 | 566 067 | 1 629 368 | 2 078 318 |
| Retained earnings of previous periods | 4 095 325 | 2 859 179 | 3 425 247 | 2 595 325 |
| Total assets | 44 712 692 | 38 785 526 | 40 860 559 | 43 683 854 |
| Total liabilities | 40 236 654 | 35 228 929 | 35 696 022 | 38 921 823 |
| Total equity | 4 371 679 | 3 455 246 | 5 084 615 | 4 703 643 |
| Calculated dividends | — | 1 482 500 | 0 | 2 459 290 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Documents in the Register of Financial Statements16
- 2025 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2025 Správa audítora
- 2025 Úč POD · 12 pp.
- 2025 Úč POD
- 2024 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2024 Správa audítora
- 2024 Úč POD · 12 pp.
- 2024 Úč POD
- 2023 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2023 Správa audítora
- 2023 Úč POD · 12 pp.
- 2023 Úč POD
- 2022 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2022 Správa audítora
- 2022 Úč POD · 12 pp.
- 2022 Úč POD
Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).
Similar companies
- L.A. MEDICAL s. r. o. · Piešťany
- TATRA – ALPINE SK s.r.o. · Bratislava - mestská časť Ružinov
- MEDACO Plus s. r. o. · Bratislava - mestská časť Petržalka
- Doropharm Health s.r.o. · Bratislava - mestská časť Nové Mesto
- TIMED, s.r.o. · Bratislava
- UNOMED spol. s r. o. UNOMED GmbH. - v jazyku nemeckom UNOMED Ltd. - v jazyku anglickom · Trenčín
- EGAMED, spol. s r.o. · Ratnovce
- R A D I X spol. s r.o. · Banská Bystrica
- DGB consult, s. r. o. · Žilina
- INTEC PHARMA s.r.o. · Bratislava